🇺🇸 FDA
Pipeline program

Descartes-08

RNAC-TRITON-08

Phase 2 small_molecule active

Quick answer

Descartes-08 for Antisynthetase Syndrome is a Phase 2 program (small_molecule) at Cartesian Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Cartesian Therapeutics
Indication
Antisynthetase Syndrome
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials